News

Stocktwits on MSN22h
Eli Lilly’s Alzheimer’s Drug Gets US FDA Label Update For More Gradual Dosing After Study Shows Reduced Side Effects
Eli Lilly and Company (LLY) announced on Wednesday that the U.S. Food and Drug Administration (FDA) has approved a label ...
BioPharma Dive18h
Lilly gets FDA OK of modified dosing for Alzheimer’s drug
A slower ramp-up of Kisunla dosing lowers the rate of dangerous brain swelling, a risk that has made doctors reluctant to ...
BioSpace1d
Lilly Gets FDA Label Update for Alzheimer’s Drug To Mitigate Safety Concerns
The FDA will allow a new dosing schedule for Eli Lilly’s Alzheimer’s drug Kisunla that could lessen a known side effect of ...
Washington Times2y
Alzheimer’s drug gets FDA panel’s backing, setting the stage for broader use - Washington Times
Alzheimer’s drug gets FDA panel’s backing, setting the stage for broader use FILE - This Dec. 21, 2022, image provided by Eisai in January 2023 shows vials and packaging for their medication ...
Fox News1y
Experimental Alzheimer’s drug gets FDA advisory panel's thumbs-up: ‘Progress is happening’ - Fox News
Experimental Alzheimer’s drug gets FDA advisory panel's thumbs-up: ‘Progress is happening’ If approved, Eli Lilly’s drug, donanemab, would be second medication to treat and slow early symptoms ...
Las Vegas Sun2y
Alzheimer's drug gets FDA panel's backing, setting the stage for broader use
Alzheimer's drug gets FDA panel's backing, setting the stage for broader use Eisai via AP, file This Dec. 21, 2022, image provided by Eisai in January 2023 shows vials and packaging for their ...
Detroit News2y
Alzheimer's drug gets FDA panel's backing, setting the stage for ...
Washington – Health advisers on Friday unanimously backed the full approval of a closely watched Alzheimer’s drug, a key step toward opening insurance coverage to U.S. seniors with early ...
NBC New York2y
Alzheimer's drug gets FDA panel's backing, setting the stage for broader use - NBC New York
Health advisers on Friday unanimously backed the full approval of a closely watched Alzheimer’s drug, a key step toward opening insurance coverage to U.S. seniors with early stages of the brain ...
WRIC2y
Alzheimer’s drug gets FDA panel’s backing, setting the stage for broader use - WRIC ABC 8News
WASHINGTON (AP) — Health advisers on Friday unanimously backed the full approval of a closely watched Alzheimer’s drug, a key step toward opening insurance coverage to U.S. seniors with early ...
WPRI 122y
Alzheimer’s drug gets FDA panel’s backing, setting the stage for ...
Health advisers on Friday unanimously backed the full approval of a closely watched Alzheimer’s drug, a key step toward opening insurance coverage to U.S. seniors with early stages of the brain ...
clickondetroit.com2y
Alzheimer's drug gets FDA panel's backing, setting the stage for ...
The drug, marketed by Eisai and Biogen, helped clear a brain plaque that is a hallmark of Alzheimer’s. The FDA panel reviewed more recent data from an 1,800-patient study in which people taking ...
KTLA2y
Alzheimer’s drug gets FDA panel’s backing, setting the stage for broader use - KTLA
WASHINGTON (AP) — Health advisers on Friday unanimously backed the full approval of a closely watched Alzheimer’s drug, a key step toward opening insurance coverage to U.S. seniors with early ...